Platelets

Papers
(The median citation count of Platelets is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
ArticleCitations
Immunothrombosis and thromboinflammation in host defense and disease92
A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients51
Platelet Rich Plasma in Orthopedic Surgical Medicine.49
Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative medicine39
PRP in wound healing applications38
Platelet calcium signaling by G-protein coupled and ITAM-linked receptors regulating anoctamin-6 and procoagulant activity35
Platelet rich plasma in oral and maxillofacial surgery from the perspective of composition34
A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors33
Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases32
The thrombopoietin receptor: revisiting the master regulator of platelet production31
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients30
Role of platelets and megakaryocytes in adaptive immunity30
In vivo evaluation of the biocompatibility and biodegradation of a new denatured plasma membrane combined with liquid PRF (Alb-PRF)30
Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty29
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure27
Rotational thromboelastometry (ROTEM) profiling of COVID–19 patients25
Neonatal platelet physiology and implications for transfusion24
Platelet-rich plasma promotes bone formation, restrains adipogenesis and accelerates vascularization to relieve steroids-induced osteonecrosis of the femoral head24
Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension23
Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous 22
Platelet removal by single-step centrifugation21
Platelets and viruses21
Isolation of murine bone marrow by centrifugation or flushing for the analysis of hematopoietic cells – a comparative study21
Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib20
Application of Platelet Rich Fibrin in Tissue Engineering: Focus on Bone Regeneration20
The structure of CLEC-2: mechanisms of dimerization and higher-order clustering20
Extensive characterization of the composition and functional activities of five preparations of human platelet lysates for dedicated clinical uses18
Early recognition of sepsis-induced coagulopathy using the C2PAC index: a ratio of soluble type C lectin-like receptor 2 (sCLEC-2) level and platelet count18
Human platelet lysates for human cell propagation18
Platelets and renal failure in the SARS-CoV-2 syndrome17
MicroRNA-126 is a regulator of platelet-supported thrombin generation17
Platelet–leukocyte interactions in the pathogenesis of viral infections17
Novel antiplatelet targets in the treatment of acute coronary syndromes17
Bioinspired artificial platelets: past, present and future16
Immobilized collagen prevents shedding and induces sustained GPVI clustering and signaling in platelets16
Structure-function relationship of the platelet glycoprotein VI (GPVI) receptor: does it matter if it is a dimer or monomer?15
The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysis15
The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis14
Alterations in platelets during SARS-CoV-2 infection14
EDTA stabilizes the concentration of platelet-derived extracellular vesicles during blood collection and handling14
Platelets in dengue infection: more than a numbers game13
Release of α-granule contents during platelet activation13
Cytosolic and mitochondrial Ca2+ signaling in procoagulant platelets13
Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets13
Platelet reticulated forms, size indexes and functional activity. Interactions in healthy volunteers.13
Frozen and cold-stored platelets: reconsidered platelet products13
Left ventricular assist device implantation causes platelet dysfunction and proinflammatory platelet-neutrophil interaction12
Efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia: stage 2 results from a multicenter phase III study12
Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function12
Platelet count and function in umbilical cord blood versus peripheral blood in term neonates12
Diagnostic and prognostic role of platelets in patients with sepsis and septic shock12
Targeting platelet inhibition receptors for novel therapies: PECAM-1 and G6b-B12
Zinc: an endogenous and exogenous regulator of platelet function during hemostasis and thrombosis12
Severe thrombocytopenia in adults undergoing extracorporeal membrane oxygenation is predictive of thrombosis12
Platelet activation by charged ligands and nanoparticles: platelet glycoprotein receptors as pattern recognition receptors11
ABCG5 and ABCG8 gene variations associated with sitosterolemia and platelet dysfunction11
Antiplatelet drugs and liver fibrosis11
Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-211
Harmonizing light transmission aggregometry in the Netherlands by implementation of the SSC-ISTH guideline11
Platelet Function Assays for the Diagnosis of Aspirin Resistance11
In vitro evaluation of platelet extracellular vesicles (PEVs) for corneal endothelial regeneration11
Platelet-derived microparticles stimulated by anti-β 2 GPI/β 2 GPI complexes induce pyroptosis of endothelial cells in antiphospho11
Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy10
Injectable platelet-rich fibrin positively regulates osteogenic differentiation of stem cells from implant hole via the ERK1/2 pathway10
Thrombocytopenia and platelet count recovery in patients with sepsis-3: a retrospective observational study10
New oral protease-activated receptor 4 antagonist BMS-986120: tolerability, pharmacokinetics, pharmacodynamics, and gene variant effects in humans10
Prevalence and natural history of variants in the ANKRD26 gene: a short review and update of reported cases10
The efficacy and safety of CYP2C19 genotype-guided antiplatelet therapy compared with conventional antiplatelet therapy in patients with acute coronary syndrome or undergoing percutaneous coronary int10
In vitro-derived platelets: the challenges we will have to face to assess quality and safety10
GPIb-IX-V and platelet clearance9
Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia9
The enigmatic nature of the triggering receptor expressed in myeloid cells -1 (TLT- 1)9
Selective inhibition of thromboinflammation in COVID-19 by Btk inhibitors9
Effect of differently coated silver nanoparticles on hemostasis9
Sex differences in antiplatelet therapy: state-of-the art9
Immature platelet indices alongside procalcitonin for sensitive and specific identification of bacteremia in the intensive care unit9
Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-199
High extracellular phosphate increases platelet polyphosphate content9
High-efficiency unassisted transfection of platelets with naked double-stranded miRNAs modulates signal-activated translation and platelet function9
A proprietary GMP human platelet lysate for the expansion of dermal fibroblasts for clinical applications9
Mechanisms of platelet release: in vivo studies and in vitro modeling9
P2X1: a unique platelet receptor with a key role in thromboinflammation9
Apoptosis is one cause of thrombocytopenia in patients with high-altitude polycythemia9
Higher body mass index raises immature platelet count: potential contribution to obesity-related thrombosis9
Association of lipoprotein(a) with platelet aggregation and thrombogenicity in patients undergoing percutaneous coronary intervention8
Distribution and quantification of activated platelets in platelet-rich fibrin matrices8
Structural analysis of resting mouse platelets by 3D-EM reveals an unexpected variation in α-granule shape8
Whole blood flow cytometry protocol for the assessment of platelet phenotype, function, and cellular interactions8
Platelet-derived respiratory-competent mitochondria transfer to mesenchymal stem cells to promote wound healing via metabolic reprogramming8
Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology8
Factor Xa and thrombin induce endothelial progenitor cell activation. The effect of direct oral anticoagulants8
Evolution of platelet activation parameters during septic shock in intensive care unit8
Platelets enhance CD4+ central memory T cell responses via platelet factor 4-dependent mitochondrial biogenesis and cell proliferation8
Refractory immune thrombocytopenia successfully treated with bortezomib in a child with 22q11.2 deletion syndrome, complicated by Evans syndrome and hypogammaglobulinemia7
The potency of selatogrel, a reversible antagonist of the P2Y12 receptor, is affected by calcium concentration7
Pathogen inactivation of platelets for transfusion7
Helicobacter pylori protein that binds to and activates platelet specifically reacts with sera of H. pylori-associated chronic immune thrombocytopenia7
Management of immune thrombotic thrombocytopenic purpura with caplacizumab: a Canadian, single-centre, real-world experience7
Statins potentiate the antibacterial effect of platelets on Staphylococcus aureus7
Prognostic significance of thrombocytosis in lung cancer: a systematic review and meta-analysis7
Association between platelet counts and morbidity and mortality after endovascular repair for type B aortic dissection7
Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention: a GLOBAL LEADERS su7
Platelets: bridging thrombosis and inflammation7
Platelet-derived mitochondria transfer facilitates wound-closure by modulating ROS levels in dermal fibroblasts7
Enrichment of plasma in platelets and extracellular vesicles by the counterflow to erythrocyte settling7
Signaling mechanisms of the platelet glycoprotein Ib-IX complex7
New presentations and exacerbations of immune thrombocytopenia after coronavirus disease 2019 vaccinations: the Taiwan experience7
Reply to “Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis”7
Characteristics of L-PRP preparations for treating Achilles tendon rupture within the PATH-2 study7
Human Platelets and Influenza Virus: Internalization and Platelet Activation7
Optimized tool for evaluation of platelet function measured by impedance aggregometry7
Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices6
“Tailored” antiplatelet bridging therapy with cangrelor: moving toward personalized medicine6
Whole blood platelet aggregation measurement by Multiplate™: potential diagnostic inaccuracy of correcting the results for the sample platelet count6
Mean platelet volume: a prognostic marker in heart failure with preserved ejection fraction6
The role of viscoelastic testing in assessing peri-interventional platelet function and coagulation6
Comparison of antiplatelet antibody profiles between hepatitis C virus-associated immune thrombocytopenia and primary immune thrombocytopenia6
Potential contrasting effects of platelets on the migration and invasion of sarcomas versus carcinomas6
Novel antiplatelet strategies targeting VWF and GPIb6
Relationship between Hepatitis B virus infection and platelet production and dysfunction6
Circulating microRNAs as biomarkers and mediators of platelet activation6
Platelet-leukocyte aggregate formation and inflammation in patients with pulmonary arterial hypertension and CTEPH6
Flow cytometry identifies an early stage of platelet apoptosis produced by agonists of the P2X1 and P2X7 receptors6
Why do platelets express K+ channels?6
Is the endogenous ligand for PEAR1 a proteoglycan: clues from the sea6
Innate immune TLR7 signaling mediates platelet activation and platelet-leukocyte aggregate formation in murine bacterial sepsis6
Exacerbation of immune thrombocytopenia following initial and booster vaccination with Pfizer-BioNTech COVID-19 vaccine6
The efficacy of platelet rich plasma on anterior cruciate ligament reconstruction: a systematic review and meta-analysis6
Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors6
Irradiation of platelets in transfusion medicine: risk and benefit judgments6
Comparison of the effects of platelet concentrates produced by high and low-speed centrifugation protocols on the healing of critical-size defects in rat calvaria: a microtomographic and histomorphome6
Platelet count and risk of major bleeding in venous thromboembolism5
The effect of platelet-rich plasma injection on chronic Achilles tendinopathy and acute Achilles tendon rupture5
Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and decreases clot strength5
Ionotropic glutamate receptors in platelets: opposing effects and a unifying hypothesis5
Efficacy of platelet transfusion in cardiac surgery5
Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization5
Effects of leukocyte-rich platelet-rich plasma and leukocyte-poor platelet-rich plasma on the healing of bone-tendon interface of rotator cuff in a mice model5
Complement activation negatively affects the platelet response to thrombopoietin receptor agonists in patients with immune thrombocytopenia: a prospective cohort study5
Hemostasis-on-a-chip / incorporating the endothelium in microfluidic models of bleeding5
Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura5
A platelet lipidomics signature in patients with COVID-195
Akt pathway activation reduces platelet apoptosis and contributes to the increase of platelet counts in solid tumor patients5
Platelet glycogenolysis is important for energy production and function5
Current challenges in platelet transfusion5
Fatal cerebral hemorrhage in a patient with thrombotic thrombocytopenic purpura with a normal platelet count during treatment with caplacizumab5
Method article: anin vitroblood flow model to advance the study of platelet adhesion utilizing a damaged endothelium5
Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis5
PTGS1 gene variations associated with bleeding and platelet dysfunction5
First-in-human study to assess the safety, pharmacokinetics, and pharmacodynamics of BMS-986141, a novel, reversible, small-molecule, PAR4 agonist in non-Japanese and Japanese healthy participants5
Platelet count and disease – editorial policy5
Catastrophic antiphospholipid syndrome refractory to high-dose intravenous immunoglobulin responsive to therapeutic plasma exchange5
Does hsa-miR-223-3p from platelet-derived extracellular vesicles regulate tissue factor expression in monocytic cells?4
Sex differences in platelet reactivity in patients with myocardial infarction treated with triple antiplatelet therapy - results from assessing platelet activity in coronary heart disease (APACHE)4
Eltrombopag modulates the phenotypic evolution and potential immunomodulatory roles of monocytes/macrophages in immune thrombocytopenia4
Romiplostim for PARP inhibitor-induced thrombocytopenia in solid tumor malignancies4
Rapid isolation of mature murine primary megakaryocytes by size exclusion via filtration4
Combining human platelet proteomes and transcriptomes: possibilities and challenges4
Pro-apoptotic properties and mitochondrial functionality in platelet-like-particles generated from low Aspirin-incubated Meg-01 cells4
Expression of ADP receptor P2Y12, thromboxane A2 receptor and C-type lectin-like receptor 2 in cord blood-derived megakaryopoiesis4
A novel RUNX1 exon 3 - 7 deletion causing a familial platelet disorder4
Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI4
The Total Thrombus Formation (T-TAS) platelet (PL) assay, a novel test that evaluates whole blood platelet thrombus formation under physiological conditions4
Profile of reticulated platelets in the early, subacute and late phases after transient ischemic attack or ischemic stroke4
Platelet parameters and risk of hypertension disorders of pregnancy: a propensity score adjusted analysis4
Potential biomarkers for inherited thrombocytopenia 2 identified by plasma proteomics4
High fragmentation in platelet concentrates impacts the activation, procoagulant, and aggregatory capacity of platelets4
Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure4
Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic review4
Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study4
Mind the gap: connexins and pannexins in platelet function4
ADP-induced platelet reactivity and bleeding events in patients with acute myocardial infarction complicated by cardiogenic shock4
The utility of platelet activation biomarkers in thrombotic microangiopathies4
Contributing role of mitochondrial energy metabolism on platelet adhesion, activation and thrombus formation under blood flow conditions4
Developmental differences of in vitro cultured murine bone marrow- and fetal liver-derived megakaryocytes4
Effect of leukocyte-platelet fibrin-rich wound reconstruction followed by full-thickness skin grafting in the treatment of diabetic foot Wagner grade 4 ulcer gangrene (toe area)4
Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age4
Immature platelets in COVID-194
Effects of remote ischemic preconditioning on platelet activation and reactivity in patients undergoing cardiac surgery using cardiopulmonary bypass: a randomized controlled trial4
Pre-operative platelet reactivity is a strong, independent predictor of bleeding complications after branched endovascular thoracoabdominal aortic aneurysm repair4
Aquaporins in platelet function4
Acquired platelet defect associated with gabapentin treatment: a case-report4
Effect of iron supplementation on platelet count in adult patients with iron deficiency anemia4
Platelet surface GPIbα, activated GPIIb-IIIa, and P-selectin levels in adult veno-arterial extracorporeal membrane oxygenation patients4
Hiding in plain sight – platelets, the silent carriers of HIV-13
Thrombus remodelling by reversible and irreversible P2Y 12 inhibitors3
Pathogenic mechanisms contributing to thrombocytopenia in patients with systemic lupus erythematosus3
Severe thrombocytopenia and intracranial hemorrhage in a newborn with Noonan syndrome and neonatal alloimmune thrombocytopenia3
Significance of mild thrombocytopenia in maintenance hemodialysis patients; a retrospective cohort study3
Platelets after burn injury – hemostasis and beyond3
Evening aspirin intake results in higher levels of platelet inhibition and a reduction in reticulated platelets - a window of opportunity for patients with cardiovascular disease?3
Healthy pediatric platelets are moderately hyporeactive in comparison with adults’ platelets3
Cold stored platelets in the management of bleeding: is it about bioenergetics?3
Successful treatment of acquired amegakaryocytic thrombocytopenia with eltrombopag and immunosuppressant3
Intravenous abciximab as a rescue therapy for immediate reocclusion after successful mechanical thrombectomy in acute ischemic stroke patients3
The utility of flow cytometric platelet forward scatter as an alternative to mean platelet volume3
The state of the art and future of PRP therapy3
How can we use proteomics to learn more about platelets?3
Mapping densely packed αIIbβ3 receptors in murine blood platelets with expansion microscopy3
What can we learn from senescent platelets, their transcriptomes and proteomes?3
Not-high before-treatment platelet reactivity in patients with STEMI: prevalence, clinical characteristics, response to therapy and outcomes3
Reversible cross-tolerance to platelet-activating factor signaling by bacterial toxins3
Roles of non-coding RNA in megakaryocytopoiesis and thrombopoiesis: new target therapies in ITP3
α-Synuclein is the major platelet isoform but is dispensable for activation, secretion, and thrombosis3
Evaluating stored platelet shape change using imaging flow cytometry3
Building platelet phenotypes: Diaphanous-related formin 1 (DIAPH1)-related disorder3
Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications3
Effects of platelets activated by different agonists on fibrin formation and thrombin generation3
Determination of fibrin clot growth and spatial thrombin propagation in the presence of different types of phospholipid surfaces3
Absence of bleeding upon dual antiplatelet therapy in a patient with a immune GPVI deficiency3
Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry3
Efficacy and safety of abciximab versus tirofiban in addition to ticagrelor in STEMI patients undergoing primary percutaneous intervention3
The effect of short-term cryopreservation on the properties and functionality of platelet-rich plasma3
GALE variants associated with syndromic manifestations, macrothrombocytopenia, bleeding, and platelet dysfunction3
Inflammatory state does not affect the antiplatelet efficacy of potent P2Y12 inhibitors in ACS3
New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains3
Actin polymerization regulates glycoprotein Ibα shedding3
The plant hormone abscisic acid stimulates megakaryocyte differentiation from human iPSCs in vitro3
EDI(torial): equality, diversity, and inclusion and platelets - 20213
F11R/JAM-A: why do platelets express a molecule which is also present in tight junctions?3
Feasibility of a mean platelet volume standard: an international council for standardization in hematology (ICSH) inter-laboratory study3
An optimized agonist peptide of protease-activated receptor 4 and its use in a validated platelet-aggregation assay3
What can we learn from the platelet lipidome?3
High-molecular-weight fucosylated glycosaminoglycan induces human platelet aggregation depending on αIIbβ3 and platelet secretion3
Whole blood dynamic platelet aggregation counting and 1-year clinical outcomes in patients with coronary heart diseases treated with clopidogrel3
Effects of electret coating technology on coronary stent thrombogenicity3
A novel frameshiftGP1BBmutation causes autosomal dominant macrothrombocytopenia with decreased vWF receptor expression but normal platelet aggregation3
Efficacy and safety of short-term 1–3 months versus standard 12 months dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trial3
Correlation of CLEC1B haplotypes with plasma levels of soluble CLEC-2 in healthy individuals3
Immature platelets and cardiovascular events in patients with stable coronary artery disease3
0.057348966598511